Concepedia

Schedule Ii Classification

Schedule II Classification is a regulatory categorization within the framework of controlled substance scheduling that designates substances with a high potential for abuse and currently accepted medical use in the United States, distinguished from other schedules by permitting restricted medical application despite stringent control measures.

14

Publications

623

Citations

81

Authors

32

Institutions

Publications per year

2017–2026

8

Parents

Publications

14

Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002

Gary M. Franklin, Jaymie Mai, Thomas M. Wickizer et al. · American Journal of Industrial Medicine · 2005 · 159 citations

, , +15

Doctor and Pharmacy Shopping for Controlled Substances

Gretchen L. Peirce, Michael J. Smith, Marie A. Abate et al. · Medical Care · 2012 · 154 citations

, , +12

Decline in opioid prescribing after federal rescheduling of hydrocodone products

Mukaila A. Raji, Yong‐Fang Kuo, Deepak Adhikari et al. · Pharmacoepidemiology and Drug Safety · 2017 · 62 citations · Full text

, , +17

Medicare Letters To Curb Overprescribing Of Controlled Substances Had No Detectable Effect On Providers

Adam Sacarny, David Yokum, Amy Finkelstein et al. · Health Affairs · 2016 · 59 citations · Full text

, , +17

Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone

Ashley Haynes, Kurt Kleinschmidt, Mathias B. Forrester et al. · Clinical Toxicology · 2016 · 32 citations

, , +17

1–5 of 14

Authors

81

  1. MT
    Mito Takeshita

    University of Massachusetts Chan Medical School, United States

    1 publications · 20 citations

    1

    h-index

  2. JL
    Jianghai Lu

    China Anti-Doping Agency, China

    1 publications · 15 citations

    1

    h-index

  3. IL
    Ina Liu

    University of North Carolina at Chapel Hill, United States

    1 publications · 20 citations

    1

    h-index

  4. CT
    Casey Tak

    University of Utah, United States

    1 publications · 20 citations

    1

    h-index

  5. PJ
    Paul Jeffrey

    University of Massachusetts Chan Medical School, United States

    1 publications · 20 citations

    1

    h-index

1–5 of 81

Institutions

32

  1. Mass General Brigham

    Boston, United States

    1 h-index

    1 publications

    22 citations

  2. Bedford VA Research Corporation

    Bedford, United States

    1 h-index

    1 publications

    12 citations

  3. Abdul Latif Jameel Poverty Action Lab

    Cambridge, United States

    1 h-index

    3 publications

    177 citations

  4. University of North Carolina Health Care

    Chapel Hill, United States

    1 h-index

    1 publications

    20 citations

  5. Massachusetts General Hospital

    Boston, United States

    1 h-index

    1 publications

    22 citations

  6. New York University Langone Orthopedic Hospital

    New York, United States

    1 h-index

    4 publications

    48 citations

  7. Colorado State University

    Fort Collins, United States

    1 h-index

    2 publications

    56 citations

  8. Innovation Team (China)

    Hong Kong, China

    1 h-index

    1 publications

    15 citations

1–8 of 32

Venues

  1. Southern Medical Journal

    SMJ · 1 publications · 17 citations

    1

    h-index

  2. American Journal of Health-System Pharmacy

    AJHP · 1 publications · 20 citations

    1

    h-index

  3. PubMed

    Repository · 1 publications · 12 citations

    1

    h-index

  4. Pharmacoepidemiology and Drug Safety

    1 publications · 62 citations

    1

    h-index

  5. Clinical Toxicology

    1 publications · 32 citations

    1

    h-index

1–5